Dr Josep Tabernero

Josep is Head of the Medical Oncology Department at Vall d’Hebron University Hospital, Professor of Medicine at the Universitat de Vic and Director of the Vall d’Hebron Institute of Oncology. He is also currently a member of the Cancer Mission Assembly linked to the European Commission - Cancer Mission Board of the next EU research and innovation programme, Horizon Europe.

He has designed a number of investigator-initiated clinical trials aimed to answer relevant questions in CRC research. He has participated and contributed to the design of a number of clinical trials, many of them developed in the context of national and international cooperative groups and some sponsored directly by pharmaceutical companies. The research work of his group (The Gastrointestinal and Endocrine Tumours Group) is focused towards the development of molecular targeted therapies and the identification of molecular biomarkers of response/ resistance, and it is formed by both clinical and translational researchers, working in various thematic areas (sophisticated preclinical models, liquid biopsies, microbiome).